Latest News
RHYTHM AI Receives MHRA Approval to Initiate the ROCSTAR Clinical Trial with STAR Mapping System
RHYTHM AI Receives MHRA Approval to Initiate the ROCSTAR Clinical Trial with STAR Mapping™ System UK Multi-Centre Trial to Recruit 177 Patients in up to 15 [...]
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster Companies to collaborate on multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment [...]
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF The use of a Stochastic Trajectory Analysis [...]
RHYTHM AI Successfully Closes Seed Financing Round
Proceeds to fund multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment London, UK- 10 September 2019: RHYTHM AI Ltd ("RHYTHM AI" [...]
STAR Mapping Outcome Study in AF
RHYTHM AI Ltd Announces publication of Human Clinical Outcome Study for STAR Mapping™ System for Treatment of Persistent Atrial Fibrillation 80% of patients treated for persistent [...]
STAR Mapping Licence Agreement
RHYTHM AI Ltd and Barts NHS Trust enter into an Exclusive Worldwide Licence Agreement for STAR Mapping™ Technology for Treatment of Atrial Fibrillation Oxford, UK- April [...]